空肠弯曲菌对27种抗菌药物以及β-内酰胺类与克拉维酸或舒巴坦的各种组合的体外敏感性。
In vitro susceptibility of Campylobacter jejuni to 27 antimicrobial agents and various combinations of beta-lactams with clavulanic acid or sulbactam.
作者信息
Van der Auwera P, Scorneaux B
出版信息
Antimicrob Agents Chemother. 1985 Jul;28(1):37-40. doi: 10.1128/AAC.28.1.37.
Abstract
The in vitro susceptibility of human isolates of Campylobacter jejuni was investigated with 27 antibiotics and 8 combinations of beta-lactams with clavulanic acid or sulbactam. Ansamycin, the new quinolines, erythromycin, and cefpirome were the most active drugs against C. jejuni; amoxicillin, ampicillin, cefotaxime, and ceftazidime 90% of the isolates, greater than or equal to 50 mg/liter). The activity of various beta-lactams was unchanged by the addition of clavulanic acid or sulbactam.
摘要
用27种抗生素以及8种β-内酰胺类与克拉维酸或舒巴坦的组合，对空肠弯曲菌的人体分离株进行了体外药敏试验。安莎霉素、新型喹诺酮类、红霉素和头孢匹罗是对空肠弯曲菌最具活性的药物；阿莫西林、氨苄西林、头孢噻肟和头孢他啶对90%的分离株有效（大于或等于50毫克/升）。添加克拉维酸或舒巴坦后，各种β-内酰胺类的活性未发生变化。
相似文献
1
In vitro susceptibility of Campylobacter jejuni to 27 antimicrobial agents and various combinations of beta-lactams with clavulanic acid or sulbactam.
Antimicrob Agents Chemother. 1985 Jul;28(1):37-40. doi: 10.1128/AAC.28.1.37.
2
Antimicrobial susceptibilities of Campylobacter jejuni and Campylobacter coli to 12 beta-lactam agents and combinations with beta-lactamase inhibitors.
Antimicrob Agents Chemother. 1996 Aug;40(8):1924-5. doi: 10.1128/AAC.40.8.1924.
3
Susceptibilities of beta-lactamase-positive and -negative strains of Campylobacter coli to beta-lactam agents.
Antimicrob Agents Chemother. 1993 May;37(5):1174-6. doi: 10.1128/AAC.37.5.1174.
4
Comparative activity of beta-lactamase inhibitors YTR 830, clavulanate, and sulbactam combined with beta-lactams against beta-lactamase-producing anaerobes.
Antimicrob Agents Chemother. 1986 Nov;30(5):789-91. doi: 10.1128/AAC.30.5.789.
5
Interaction of clavulanic acid, sulbactam and cephamycin antibiotics with beta-lactamases.
Drugs Exp Clin Res. 1987;13(3):145-8.
6
7
Relative efficacy of tazobactam, sulbactam and clavulanic acid in enhancing the potency of ampicillin against clinical isolates of Enterobacteriaceae.
Eur J Clin Microbiol Infect Dis. 1993 Mar;12(3):200-5. doi: 10.1007/BF01967112.
8
In-vitro evaluation of the four beta-lactamase inhibitors: BRL42715, clavulanic acid, sulbactam, and tazobactam.
J Antimicrob Chemother. 1993 Sep;32(3):421-9. doi: 10.1093/jac/32.3.421.
9
In vitro activities of the beta-lactamase inhibitors clavulanic acid, sulbactam, and tazobactam alone or in combination with beta-lactams against epidemiologically characterized multidrug-resistant Acinetobacter baumannii strains.
Antimicrob Agents Chemother. 2004 May;48(5):1586-92. doi: 10.1128/AAC.48.5.1586-1592.2004.
10
Evolution of beta-lactamase inhibitors.
Rev Infect Dis. 1991 Jul-Aug;13 Suppl 9:S727-32. doi: 10.1093/clinids/13.supplement_9.s727.
引用本文的文献
1
Overlap of Antibiotic Resistant MLST Genotypes Isolated From Humans, Broiler Products, Dairy Cattle and Wild Birds in Lithuania.
Front Microbiol. 2019 Jun 19;10:1377. doi: 10.3389/fmicb.2019.01377. eCollection 2019.
2
Antimicrobial susceptibilities of Campylobacter jejuni and Campylobacter coli to 12 beta-lactam agents and combinations with beta-lactamase inhibitors.
Antimicrob Agents Chemother. 1996 Aug;40(8):1924-5. doi: 10.1128/AAC.40.8.1924.
3
Clinical pharmacokinetics of rifabutin.
Clin Pharmacokinet. 1995 Feb;28(2):115-25. doi: 10.2165/00003088-199528020-00003.
4
Susceptibilities of fluoroquinolone-resistant strains of Campylobacter jejuni to 11 oral antimicrobial agents.
Antimicrob Agents Chemother. 1995 Feb;39(2):542-44. doi: 10.1128/AAC.39.2.542.
5
Effect of clavulanic acid on susceptibility of Campylobacter jejuni and Campylobacter coli to eight beta-lactam antibiotics.
Antimicrob Agents Chemother. 1987 Jun;31(6):940-2. doi: 10.1128/AAC.31.6.940.
6
Ofloxacin. A review of its antibacterial activity, pharmacokinetic properties and therapeutic use.
Drugs. 1987 Apr;33(4):346-91. doi: 10.2165/00003495-198733040-00003.
7
Ciprofloxacin. A review of its antibacterial activity, pharmacokinetic properties and therapeutic use.
Drugs. 1988 Apr;35(4):373-447. doi: 10.2165/00003495-198835040-00003.
8
Enoxacin. A review of its antibacterial activity, pharmacokinetic properties and therapeutic use.
Drugs. 1988 Jul;36(1):32-66. doi: 10.2165/00003495-198836010-00004.
9
Comparative in vitro activity of ceftibuten (Sch 39720) against bacterial enteropathogens.
Antimicrob Agents Chemother. 1989 May;33(5):781-4. doi: 10.1128/AAC.33.5.781.
10
Fluoroquinolone antimicrobial agents.
Clin Microbiol Rev. 1989 Oct;2(4):378-424. doi: 10.1128/CMR.2.4.378.
本文引用的文献
1
Pharmacokinetics of amoxicillin and clavulanic acid administered alone and in combination.
Antimicrob Agents Chemother. 1982 Sep;22(3):353-7. doi: 10.1128/AAC.22.3.353.
2
Effect of erythromycin on the fecal excretion of Campylobacter fetus subspecies jejuni.
J Infect Dis. 1982 Jan;145(1):128. doi: 10.1093/infdis/145.1.128.
3
Treatment of travelers' diarrhea with trimethoprim/sulfamethoxazole and with trimethoprim alone.
N Engl J Med. 1982 Sep 30;307(14):841-4. doi: 10.1056/NEJM198209303071401.
4
Studies of Campylobacter jejuni in patients with inflammatory bowel disease.
Gastroenterology. 1984 Jan;86(1):33-8.
5
Comparative in vitro activities of ten antimicrobial agents against bacterial enteropathogens.
Antimicrob Agents Chemother. 1983 Oct;24(4):509-13. doi: 10.1128/AAC.24.4.509.
6
Erythromycin in treatment of Campylobacter enteritis in children.
Am J Dis Child. 1983 Mar;137(3):286-8. doi: 10.1001/archpedi.1983.02140290072019.
7
Changes in the pharmacokinetics of ciprofloxacin and fecal flora during administration of a 7-day course to human volunteers.
Antimicrob Agents Chemother. 1984 Nov;26(5):757-61. doi: 10.1128/AAC.26.5.757.
8
Selective decontamination of the digestive tract by pipemidic acid.
Antimicrob Agents Chemother. 1983 Dec;24(6):902-4. doi: 10.1128/AAC.24.6.902.
9
Incidence of trimethoprim-sulfamethoxazole-resistant enterobacteriaceae among transplant recipients.
J Infect Dis. 1984 Nov;150(5):699-706. doi: 10.1093/infdis/150.5.699.
10
Hypoprothrombinemia in febrile, neutropenic patients with cancer: association with antimicrobial suppression of intestinal microflora.
J Infect Dis. 1984 Aug;150(2):202-12. doi: 10.1093/infdis/150.2.202.
Zotero 插件